Trial Profile
Aromatase Inhibitors versus levonorgestrel-realeasing intrauterine device for the treatment of moderate to severe endometriosis[INHIBIDORES DE LA AROMATASA (ANASTROZOL) ASOCIADOS A DISPOSITIVO INTRAUTERINO LIBERADOR DE LEVONORGESTREL (DIU-LNG) EN EL TRATAMIENTO DE LA ENDOMETRIOSIS MODERADA/SEVERA]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Levonorgestrel
- Indications Endometriosis
- Focus Therapeutic Use
- 25 Aug 2011 New trial record